Cyber-wellness Means Cyber-awareRead more Addressing maternal mental healthcare in AfricaRead more Qatar v. Ecuador to kick off FIFA World Cup 2022™ on 20 NovemberRead more Webb Fontaine Announces Launch of Niger National Single Window (NNSW) to Bolster TradeRead more Ethiopia: Loan from United Nations Fund Allows Food and Agriculture Organization (FAO) to Scale Up Fertilizers for Farmers in TigrayRead more How Choosing the Right Printer Helps Small Businesses and Content Creators to Save Time, Maximise Productivity and Achieve GrowthRead more Eritrea: World Breastfeeding WeekRead more Eritrean community festival in Scandinavian countriesRead more IOM: Uptick in Migrants Heading Home as World Rebounds from COVID-19Read more Network International & Infobip to offer WhatsApp for Business Banking Services to Financial Institution Clients across AfricaRead more

Bayer to pay $1.6 bn to settle US claims over birth control device

Print Friendly and PDF

Aug 21, 2020 - 03:11 AM

WASHINGTON — Pharmaceutical giant Bayer announced Thursday it had agreed to pay $1.6 billion to settle nearly all claims filed in the United States over controversial birth control implant Essure.

“The company will pay approximately $1.6 billion to resolve these claims, including an allowance for outstanding claims, and is in resolution discussions with counsel for the remaining plaintiffs,” the German company said in a statement.

“There is no admission of wrongdoing or liability by Bayer in the settlement agreements,” the statement said, and the settlement does not apply to claims filed in other countries.

Essure, a non-hormonal coil implant used to prevent pregnancy, has in some cases caused chronic pain, perforation of the uterus and fallopian tubes and led to hysterectomies, news reports say. It was discontinued in 2018.

Approved in the United States in 2002, the device’s perceived advantage is that it is a less invasive alternative to tubal litigation, in which a small hole is cut into the abdomen and the surgeon blocks or cuts the fallopian tube.

Bayer’s pharmaceutical division said in the second quarter it took a charge of 1.25 billion euros for litigation, primarily for claims around Essure.

All told, Bayer reported a loss of 9.55 billion euros in that quarter, which was mostly reflective of a US settlement of thousands of claims that its glyphosate weed killer may have caused cancer.

  • bio
  • twitter
  • facebook
  • latest posts

LMBCBUSINESS.COM uses both Facebook and Disqus comment systems to make it easier for you to contribute. We encourage all readers to share their views on our articles and blog posts. All comments should be relevant to the topic. By posting, you agree to our Privacy Policy. We are committed to maintaining a lively but civil forum for discussion, so we ask you to avoid personal attacks, name-calling, foul language or other inappropriate behavior. Please keep your comments relevant and respectful. By leaving the ‘Post to Facebook’ box selected – when using Facebook comment system – your comment will be published to your Facebook profile in addition to the space below. If you encounter a comment that is abusive, click the “X” in the upper right corner of the Facebook comment box to report spam or abuse. You can also email us.